Acute Myeloid Leukemia

ASH Releases New Guidelines on Treating Newly Diagnosed AML in Older Adults
August 12, 2020

The American Society of Hematology released guidelines that “take providers through the conversations they have with newly diagnosed patients, almost in real-time.”

Courtney DiNardo, MD, on Looking Forward in AML Treatment
August 05, 2020

The MD Anderson Cancer Center expert discussed the future of acute myeloid leukemia treatment, and how the field is evolving rapidly.

FDA Grants Fast Track Designation to Aspacytarabine to Treat Acute Myeloid Leukemia
August 04, 2020

Biosight Ltd announced that the FDA granted fast track designation to aspacytarabine for the treatment of adult patients aged 75 years or older with acute myeloid leukemia.